1. Bekci TT, Maden E, Emre L. Bronchial anthracofibrosis case withendobronchial tuberculosis. Int J Med Sci. 2011;8(1):84-87.
2. Kim YJ, Jung CY, Shin HW, Lee BK. Biomass smoke induced bronchialan- thracofibrosis: presenting features and clinical course. Respir Med.2009;103(5):757-765.
3. Jamaati H, Sharifi A, Mirenayat MS, et al. What do we know aboutanthracofibrosis? a literature review. Tanaffos. 2017;16(3):175-189.
4. Yılmazel Uçar E, Araz Ö, Akgün M, et al. Bronşiyal antrakozis-antrakofibrozis: potansiyel nedenler ve klinik özellikler. Eurasian JPulmonol. 2014;16(1):17-20.
5. Wynn GJ, Turkington PM, O’Driscoll BR. Anthracofibrosis, bronchialstenosis with overlying anthracotic mucosa: possibly a new occupationallung disorder: a series of seven cases from one UK hospital. Chest. 2008;134(5):1069-1073.
6. Hemmati SH, Shahriar M, Molaei NA. What causes anthracofibrosis?Either tuberculosis or smoke. Pakistan journal of medical sciences.2008;24(3):395.
7. Lee HS, Maeng JH, Park PG, et al. Clinical features of simple bronchialanthracofibrosis which is not associated with tuberculosis. TubercRespir Dis. 2002;53(5):510-518.
8. Rangelov K, Sethi S. The first described case of occupationalanthracofibrosis in the USA. Case Rep Pulmonol. 2014;14(23):460594.
9. Cho AY, Yoon HJ, Lee KY, Sun IO. Clinical characteristics of sepsis-induced acute kidney injury in patients undergoing continuous renalreplacement therapy. Renal failure. 2018;40(1):403-409.
10. Morabito S, Pistolesi V, Cibelli L, Pierucci A. Continuous renalreplacement therapies (CRRT) will remain the most widely adopteddialysis modality in the critically ill. G Ital Nefrol. 2009;26(1):13-21.
11. Güven M. Mekanik Ventilasyon Uygulamaları.
12. Yıldız F, Karakoç E. Sepsiste hemodinamik destek. Arşiv KaynakTarama Derg. 2014;23(2):157-167.
13. Prasad B, Urbanski M, Ferguson TW, Karreman E, Tangri N. Earlymortality on continuous renal replacement therapy (CRRT): the prairieCRRT study. Can J Kidney Health Dis. 2016;36(3):124.
14. Gladwin MT, Pierson DJ. Mechanical ventilation of the patient withsevere chronic obstructive pulmonary disease. Intensive Care Med.1998;24:898-910.
15. Shawwa K, Kompotiatis P, Jentzer JC, et al. Hypotension within one-hour from starting CRRT is associated with in-hospital mortality. J CritCare. 2019;54(1):7-13.
16. Flores FX, Brophy PD, Symons JM, et al. Continuous renal replacementtherapy (CRRT) after stem cell transplantation. A report from theprospective pediatric CRRT registry group. Pediatric Nephrology. 2008;23:625-630.
17. Tagami T, Matsui H, Horiguchi H, et al. Antithrombin and mortalityin severe pneumonia patients with sepsis-associated disseminatedintravascular coagulation: an observational nationwide study. J ThrombHaemost. 2014;12(9):1470-1479.
18. Foti L, Villa G, Romagnoli S, Ricci Z. Acute kidney injury andextracorporeal membrane oxygenation: review on multiple organsupport options. Int J Nephrol Renovasc Dis. 2021;13(14):321-29.
19. Guru PK, Singh TD, Akhoundi A, Kashani KB. Association ofthrombocytopenia and mortality in critically ill patients on continuousrenal replacement therapy. Nephron. 2016;133(3):175-182.
20. Wu B, Gong D, Xu B, et al. Decreased platelet count in patients receivingcontinuous veno-venous hemofiltration: a single-center retrospectivestudy. PLoS One. 2014;9(5):97286.